MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ijms26041754

Медицинская библиотека · International journal of molecular sciences · 2025

Predicting the Beneficial Effects of Cognitive Stimulation and Transcranial Direct Current Stimulation in Amnestic Mild Cognitive Impairment with Clinical, Inflammation, and Human Microglia Exposed to Serum as Potential Markers: A Double-Blind Placebo-Controlled Randomized Clinical Trial.

Alcalá-Lozano Ruth, Carmona-Hernández Rocio, Ocampo-Romero Ana Gabriela, Sosa-Millán Adriana Leticia, Morelos-Santana Erik Daniel, Abarca Diana Zapata, Castro-de-Aquino Dana Vianey, Cabrera-Muñoz Edith Araceli, Ramírez-Rodríguez Gerardo Bernabé, Sosa Ortiz Ana Luisa, Garza-Villarreal Eduardo A, Saracco-Alvarez Ricardo, González Olvera Jorge Julio

Сравнительное исследованиеСтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

In amnestic mild cognitive impairment (aMCI), neuroinflammation evolves during disease progression, affecting microglial function and potentially accelerating the pathological process. Currently, no effective treatment exists, leading to explorations of various symptomatic approaches, though few target the underlying physiological mechanisms. Modulating inflammatory processes may be critical in slowing disease progression. Cognitive stimulation (CS) and transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal cortex (l-DLPFC) show promise, but the results are heterogeneous. Thus, a randomized, double-blind, placebo-controlled clinical trial is currently underway. The first-stage results were examined after three weeks of intervention in two groups: active tDCS combined with CS and sham tDCS combined with CS. Twenty-two participants underwent two assessments: T0 (baseline) and T1 (after 15 sessions of tDCS, active or sham, and 9 sessions of CS). The results demonstrated that CS improved cognition, increased brain-derived neurotrophic factor (BDNF) levels, and reduced peripheral proinflammatory cytokine levels (interleukin IL-6 and chemokine CX3CL1) in serum. This decrease in IL-6 may promote microglial proliferation and survival as a modulatory effect response, while the increase in BDNF might suggest a regulatory mechanism in microglia-neuron interaction responses. However, tDCS did not enhance the cognitive or modulatory effects of CS, suggesting that longer interventions might be required to achieve substantial benefits.

Для цитирования: Alcalá-Lozano Ruth, Carmona-Hernández Rocio, Ocampo-Romero Ana Gabriela, Sosa-Millán Adriana Leticia, Morelos-Santana Erik Daniel, Abarca Diana Zapata, Castro-de-Aquino Dana Vianey, Cabrera-Muñoz Edith Araceli, Ramírez-Rodríguez Gerardo Bernabé, Sosa Ortiz Ana Luisa, Garza-Villarreal Eduardo A, Saracco-Alvarez Ricardo, González Olvera Jorge Julio. Predicting the Beneficial Effects of Cognitive Stimulation and Transcranial Direct Current Stimulation in Amnestic Mild Cognitive Impairment with Clinical, Inflammation, and Human Microglia Exposed to Serum as Potential Markers: A Double-Blind Placebo-Controlled Randomized Clinical Trial.. International journal of molecular sciences. 2025. DOI: 10.3390/ijms26041754.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.